Ignite Creation Date:
2025-12-24 @ 5:17 PM
Ignite Modification Date:
2025-12-28 @ 8:26 AM
Study NCT ID:
NCT04922450
Status:
UNKNOWN
Last Update Posted:
2021-06-10
First Post:
2021-05-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy for Operable Locally Advanced Head and Neck Squamous Cell Carcinoma
Sponsor:
Hunan Cancer Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-01-20
Start Date Type:
ACTUAL
Primary Completion Date:
2023-01-20
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-01-20
Completion Date Type:
ESTIMATED
First Submit Date:
2021-05-24
First Submit QC Date:
None
Study First Post Date:
2021-06-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-06-09
Last Update Post Date:
2021-06-10
Last Update Post Date Type:
ACTUAL